Switzerland fast-tracks antiviral medication against Covid-19
Remdesivir has already been granted temporary approval in other countries.
Keystone / Marcel Kusch
The Swiss health authorities have granted approval for the remdesivir drug in “record time” for treating coronavirus patients. The temporary authorisation to widen the use of the antiviral drug will be closely monitored in case of adverse side effects.
This content was published on
2 minutes
swissinfo.ch/mga
Swissmedic, the agency that oversees the use of medicaments in Switzerland, took days to fast-track approval of the drug, which is produced under the brand name Veklury by US biopharmaceutical company Gilead Sciences. The application for its extended use was only received on Monday.
It can now be used for a limited period of time to treat patients suffering from SARS-CoV-2-related pneumonia who also require oxygen.
The drug has been authorized for emergency use in the United States, India, Singapore, South Korea and Japan and has been recommended by the European Medicines Agency to treat coronavirus patients in the EU.
Swissmedic said on Thursday that it had conducted a “careful review in record time” of the drug. Hospital doctors have now been given the green light to administer the treatment. “Adverse reactions to the drug will be closely monitored in order to ensure patient safety,” read a statement.
“The product will also be made available to patients outside approved clinical trials and the approved compassionate use programme while the submitted authorisation application is being reviewed,” it added.
Clinical trials in the US on medicaments containing the active ingredient remdesivir found that the hospital stay of severely affected Covid-19 patients was shortened in almost a third of cases.
Popular Stories
More
Swiss Abroad
Heimatort, sweet Heimatort: the unique Swiss concept of home
Is your place of origin, your Heimatort, important to you?
Every Swiss citizen has a Heimatort, a place of origin, but many have never visited theirs. What’s your relationship with your Heimatort? What does it mean to you?
As a Swiss Abroad, how do you feel about the emergence of more conservative family policies in some US states?
In recent years several US states have adopted more conservative policies on family issues, abortion and education. As a Swiss citizen living there, how do you view this development?
Swiss police officer dismissed after Hitler salute at WEF
This content was published on
An employee of the crisis-ridden cantonal police force of Basel City has been dismissed after doing a Hitler salute at the World Economic Forum (WEF) in Davos.
Myanmar earthquake: foreign ministry has no news on Swiss victims
This content was published on
The Swiss foreign ministry is not yet aware of any Swiss nationals among the victims or those affected by the earthquake that struck central Myanmar.
Swiss military jet crash: air traffic controller found guilty
This content was published on
Over eight and a half years after the fatal F/A-18 military jet accident in Switzerland, an air traffic controller has been found guilty of negligent homicide by a military appeals court.
Viola Amherd hands over keys of Swiss defence ministry to Martin Pfister
This content was published on
On Friday, the new Swiss government minister Martin Pfister was symbolically presented with the keys to the Federal Department of Defence, Civil Protection and Sport by outgoing minister Viola Amherd.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Sixteen Swiss hospitals take part in coronavirus global Solidarity trial
This content was published on
Some 1,000 patients in Switzerland are expected to participate in trials of experimental treatments for Covid-19 as part of global Solidarity trial.
Fight over rights to Covid-19 drugs puts Switzerland in a tough spot
This content was published on
As calls mount for equitable access, Switzerland is caught between established practice and global solidarity in how to encourage medical innovation.
This content was published on
Swiss scientists and drug companies are playing an important role in the global effort to develop treatments or a vaccine for the virus.
Swiss hospitals launch drug trial to prevent Covid-19 infection
This content was published on
Researchers in Geneva and Basel have launched a clinical trial to test two drugs on people that have been in contact with Covid-19 patients.
Novartis steps up coronavirus fight as part of new collaboration
This content was published on
Several big pharmaceutical companies have joined forces with the Bill & Melinda Gates Foundation in response to the coronavirus pandemic.
Balancing hope and science in the search for a coronavirus cure
This content was published on
The debate surrounding the antimalarial drug hydroxychloroquine epitomises companies' balancing act between hope and scientific realities.
Covid-19 is both threat and opportunity for Swiss biotech
This content was published on
Although the coronavirus pandemic is the Swiss biotech industry’s time to shine, it has left many smaller firms struggling to survive.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.